Cite Filings / VOR / 0001346824-25-000029
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13D/A

Beneficial Ownership Report

Vor Biopharma Inc. · Filed 2025-10-27 · Acc 0001346824-25-000029

Documents 1

  • SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

  • 2025-10-30 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-10-30 4 Director sold 400,408 shares at an average $25.90 ($10,368,938)
  • 2025-10-28 8-K Regulation FD disclosure
  • 2025-10-27 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-10-27 4 Director sold 221,166 shares at an average $28.06 ($6,204,863)
  • 2025-10-22 4 Director sold 117,050 shares at an average $29.34 ($3,433,992)
  • 2025-10-20 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · Venrock Healthcare Capital Partners III, L.P. 9.9%
  2. 2026-11-16 SCHEDULE 13G/A · Chen Yu 9.2%
Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…